Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMC 365743)

Published in Proc Natl Acad Sci U S A on February 20, 2004

Authors

Antonis Voutetakis1, Marc R Kok, Changyu Zheng, Ioannis Bossis, Jianghua Wang, Ana P Cotrim, Natanya Marracino, Corinne M Goldsmith, John A Chiorini, Y Peng Loh, Lynnette K Nieman, Bruce J Baum

Author Affiliations

1: Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.

Articles citing this

HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood (2007) 1.87

Treatment of human disease by adeno-associated viral gene transfer. Hum Genet (2006) 1.84

Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J Virol (2007) 1.60

Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome. Ann Rheum Dis (2005) 1.20

Development of a gene transfer-based treatment for radiation-induced salivary hypofunction. Oral Oncol (2009) 1.15

Sorting of transgenic secretory proteins in rhesus macaque parotid glands after adenovirus-mediated gene transfer. Hum Gene Ther (2008) 1.12

AAV2-mediated transfer of the human aquaporin-1 cDNA restores fluid secretion from irradiated miniature pig parotid glands. Gene Ther (2010) 1.06

Differential sorting of human parathyroid hormone after transduction of mouse and rat salivary glands. Hum Gene Ther (2008) 1.04

Gene delivery in salivary glands: from the bench to the clinic. Biochim Biophys Acta (2011) 0.98

Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery. PLoS One (2012) 0.96

Recombinant AAV9-TLK1B administration ameliorates fractionated radiation-induced xerostomia. Hum Gene Ther (2013) 0.93

Salivary epithelial cells: an unassuming target site for gene therapeutics. Int J Biochem Cell Biol (2010) 0.93

AAV5-mediated gene transfer to the parotid glands of non-human primates. Gene Ther (2009) 0.93

Salivary PYY: a putative bypass to satiety. PLoS One (2011) 0.92

Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome. Arthritis Res Ther (2012) 0.92

Long-term transduction of miniature pig parotid glands using serotype 2 adeno-associated viral vectors. J Gene Med (2009) 0.91

Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy. Arthritis Res Ther (2012) 0.90

Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland. Endocrinology (2010) 0.90

Sorting behavior of a transgenic erythropoietin-growth hormone fusion protein in murine salivary glands. Hum Gene Ther (2008) 0.89

α-Galactosidase A expressed in the salivary glands partially corrects organ biochemical deficits in the fabry mouse through endocrine trafficking. Hum Gene Ther (2011) 0.88

Gene therapy of the rheumatic diseases: 1998 to 2008. Arthritis Res Ther (2009) 0.87

Saliva between normal and pathological. Important factors in determining systemic and oral health. J Med Life (2010) 0.87

Human parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer. Hum Gene Ther (2011) 0.86

Mouse salivary glands and human beta-defensin-2 as a study model for antimicrobial gene therapy: technical considerations. Int J Antimicrob Agents (2006) 0.85

Sorting of growth hormone-erythropoietin fusion proteins in rat salivary glands. Biochem Biophys Res Commun (2008) 0.84

TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice. Oral Dis (2011) 0.82

Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One (2011) 0.82

Convenient and reproducible in vivo gene transfer to mouse parotid glands. Oral Dis (2011) 0.81

Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active. Oral Dis (2010) 0.80

AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci (2011) 0.80

In vivo tissue-tropism of adeno-associated viral vectors. Curr Opin Virol (2016) 0.79

A novel hybrid adenoretroviral vector with more extensive E3 deletion extends transgene expression in submandibular glands. Hum Gene Ther Methods (2012) 0.79

Expression and secretion of human proinsulin-B10 from mouse salivary glands: implications for the treatment of type I diabetes mellitus. PLoS One (2013) 0.79

An AAV2/5 vector enhances safety of gene transfer to the mouse salivary gland. J Dent Res (2012) 0.78

Assessment of the safety and biodistribution of a regulated AAV2 gene transfer vector after delivery to murine submandibular glands. Toxicol Sci (2011) 0.78

Including the p53 ELAV-like protein-binding site in vector cassettes enhances transgene expression in rat submandibular gland. Oral Dis (2012) 0.78

Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glands. Oral Dis (2010) 0.77

Advances in salivary gland gene therapy - oral and systemic implications. Expert Opin Biol Ther (2015) 0.76

Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction. J Vis Exp (2016) 0.76

The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics. Arthritis Res Ther (2005) 0.76

Gene therapy. Oral Dis (2013) 0.75

In vivo secretion of the mouse immunoglobulin G Fc fragment from rat submandibular glands. J Gene Med (2009) 0.75

Articles cited by this

Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci U S A (1996) 4.76

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet (1997) 4.72

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol (1998) 4.17

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med (2001) 4.02

Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A (2000) 2.73

Genetic fate of recombinant adeno-associated virus vector genomes in muscle. J Virol (2003) 2.07

Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors. Mol Ther (2001) 1.65

Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J Clin Invest (2002) 1.63

Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci U S A (2000) 1.62

Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum Gene Ther (2002) 1.60

Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function. J Biol Chem (1988) 1.58

High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum Gene Ther (1995) 1.52

A death in the laboratory: the politics of the Gelsinger aftermath. Mol Ther (2001) 1.51

Salivary glands: a paradigm for diversity of gland development. Crit Rev Oral Biol Med (1997) 1.43

Gene therapeutics. Nature (1991) 1.39

Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther (1998) 1.35

Gene therapy on trial. Science (2000) 1.34

Gene transfer to salivary glands. Int Rev Cytol (2002) 1.28

The streaming submandibular gland. Anat Rec (1985) 1.21

Polarized secretion of transgene products from salivary glands in vivo. Hum Gene Ther (1999) 1.13

The endocrine secretion of mammalian digestive enzymes by exocrine glands. Am J Physiol (1999) 1.12

Evidence for the systemic delivery of a transgene product from salivary glands. Hum Gene Ther (1996) 1.08

Developing a convenient large animal model for gene transfer to salivary glands in vivo. J Gene Med (2004) 1.07

Hydroxychloroquine enhances the endocrine secretion of adenovirus-directed growth hormone from rat submandibular glands in vivo. Hum Gene Ther (2001) 1.02

Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Hum Gene Ther (2002) 1.00

Proliferative activity by cell type in the developing rat parotid gland. Anat Rec (1995) 0.98

Cationic liposome-mediated gene transfer to rat salivary epithelial cells in vitro and in vivo. J Gene Med (2001) 0.97

The gene as the drug. Nat Med (1995) 0.95

Cell renewal in the organs and tissues of the nongrowing adult mouse. Tex Rep Biol Med (1970) 0.94

Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream. Hum Gene Ther (2002) 0.93

Erythropoietin. Clin Lab Haematol (2001) 0.91

Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model. Mol Ther (2003) 0.91

Evaluation of salivary gland acinar and ductal cell-specific promoters in vivo with recombinant adenoviral vectors. Hum Gene Ther (2001) 0.90

Distribution and toxicity resulting from adenoviral vector administration to a single salivary gland in adult rats. J Oral Pathol Med (2003) 0.90

Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle. Blood (2000) 0.89

Long-term erythropoietin gene expression from transduced cells in bioisolator devices. Hum Gene Ther (2003) 0.86

Erythropoietin is produced by tubular cells of the rat kidney. Cell Biochem Biophys (1999) 0.85

Mechanisms leading to sustained reversion of beta-thalassemia in mice by doxycycline-controlled Epo delivery from muscles. Mol Ther (2002) 0.79

Articles by these authors

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Cushing's syndrome. Lancet (2006) 5.19

Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab (2005) 3.32

Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum (2007) 2.90

A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet (2006) 2.86

Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res (2008) 2.81

The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res (2008) 2.53

Identification of PDGFR as a receptor for AAV-5 transduction. Nat Med (2003) 2.43

A protective and broadly cross-neutralizing epitope of human papillomavirus L2. J Virol (2007) 2.36

Prophylactic treatment reduces the severity of xerostomia following radiation therapy for oral cavity cancer. Arch Otolaryngol Head Neck Surg (2003) 2.36

Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome. Arthritis Rheum (2004) 2.15

The family Parvoviridae. Arch Virol (2013) 2.12

Risk factors for positive minor salivary gland biopsy findings in Sjögren's syndrome and dry mouth patients. Arthritis Rheum (2002) 2.10

Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril (2003) 2.00

Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J Virol (2006) 1.97

CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol (2008) 1.95

Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. Proc Natl Acad Sci U S A (2011) 1.94

Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys (2010) 1.84

Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab (2005) 1.83

The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev (2005) 1.77

Btbd7 regulates epithelial cell dynamics and branching morphogenesis. Science (2010) 1.75

Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res (2006) 1.72

Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist (2010) 1.71

Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase e. Neuron (2005) 1.69

Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome. Arthritis Rheum (2009) 1.67

Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer (2004) 1.65

Dense-core secretory granule biogenesis. Physiology (Bethesda) (2006) 1.62

Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease. J Neurosurg (2009) 1.61

Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity. J Virol (2007) 1.60

AAV transcytosis through barrier epithelia and endothelium. Mol Ther (2005) 1.60

Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum Gene Ther (2002) 1.60

miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol (2013) 1.57

Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors. J Neurosci (2005) 1.56

Differentiation of human bone marrow-derived cells into buccal epithelial cells in vivo: a molecular analytical study. Lancet (2003) 1.56

The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Nat Med (2009) 1.55

Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther (2010) 1.51

The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res (2004) 1.51

Structure of adeno-associated virus serotype 5. J Virol (2004) 1.50

Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency. Hum Mol Genet (2006) 1.47

Structure of adeno-associated virus type 4. J Virol (2005) 1.47

Cloning and characterization of a bovine adeno-associated virus. J Virol (2004) 1.46

Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors. J Clin Endocrinol Metab (2003) 1.44

The extended granin family: structure, function, and biomedical implications. Endocr Rev (2011) 1.43

mTOR kinase and the regulatory subunit of protein kinase A (PRKAR1A) spatially and functionally interact during autophagosome maturation. Autophagy (2007) 1.43

Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann N Y Acad Sci (2002) 1.42

Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors. Cancer Res (2008) 1.39

In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay. Hum Mutat (2008) 1.39

Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. Clin Chem (2008) 1.38

Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction. Proc Natl Acad Sci U S A (2012) 1.38

Cloning of an avian adeno-associated virus (AAAV) and generation of recombinant AAAV particles. J Virol (2003) 1.37

PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex. J Clin Endocrinol Metab (2006) 1.36

The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome. J Clin Endocrinol Metab (2004) 1.36

Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum (2004) 1.36

Large deletions of the PRKAR1A gene in Carney complex. Clin Cancer Res (2008) 1.36

Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res (2007) 1.34

The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral deficits. Endocrinology (2004) 1.33

Aging: central role for autophagy and the lysosomal degradative system. Ageing Res Rev (2009) 1.31

Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev (2012) 1.30

Salivary glands: novel target sites for gene therapeutics. Trends Mol Med (2004) 1.30

Gene transfer to salivary glands. Int Rev Cytol (2002) 1.28

Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome. Hum Gene Ther (2003) 1.28

Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5. J Biol Chem (2002) 1.27

Kinetics of tempol for prevention of xerostomia following head and neck irradiation in a mouse model. Clin Cancer Res (2005) 1.27

Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species. Cancer Res (2006) 1.26

Xerostomia and the geriatric patient. J Am Geriatr Soc (2002) 1.26

Cushing's syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab (2005) 1.24

Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab (2010) 1.24

Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders. J Endocrinol (2005) 1.23

New roles of carboxypeptidase E in endocrine and neural function and cancer. Endocr Rev (2012) 1.23

Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology (2011) 1.22

Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6. Nat Med (2010) 1.22

Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol (2009) 1.20

Bone marrow-derived cells rescue salivary gland function in mice with head and neck irradiation. Int J Biochem Cell Biol (2010) 1.18

Prevention of irradiation-induced salivary hypofunction by microvessel protection in mouse salivary glands. Mol Ther (2007) 1.18

Gangliosides are essential for bovine adeno-associated virus entry. J Virol (2006) 1.17

Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 1.17

A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) (2009) 1.17

Toxicity and biodistribution of a first-generation recombinant adenoviral vector, encoding aquaporin-1, after retroductal delivery to a single rat submandibular gland. Hum Gene Ther (2006) 1.17

Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res (2005) 1.16

Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. Int J Radiat Oncol Biol Phys (2005) 1.16

The parvovirus capsid odyssey: from the cell surface to the nucleus. Trends Microbiol (2008) 1.15

RNAprotect saliva: An optimal room- temperature stabilization reagent for the salivary transcriptome. Clin Chem (2006) 1.15